GHRP-2
Nudges your body to release growth hormone, but the appetite spike that rides along is the real catch. The older, messier model in its class.
- What it is
- A peptide that copies your hunger hormone and triggers GH
- Is it FDA-approved?
- No. Sold for research only (RUO)
- How strong is the proof?
- Weak. Old, small studies. No long-term data
- How you take it
- A small shot under the skin
- Typical result
- A growth hormone bump plus a strong appetite spike
- Biggest catch
- Raises IGF-1 (a cancer worry) and is banned in sports
Any word with a dotted underline is a science word — tap it for a plain-English meaning.
In plain words.
GHRP-2 is a small , just six amino acids long. It copies a natural hormone called ghrelin. Ghrelin is the hormone that makes you feel hungry.
When you take GHRP-2, it pushes your body to release a burst of growth hormone. It also turns up your appetite. That is why it is a , which just means something that makes you release your own growth hormone.
It was briefly studied years ago for kids with short stature. It was never approved as a medicine. Today it is older and mostly outdated. Cleaner options exist.
What people use it for.
People use GHRP-2 to try to raise their own growth hormone.
The hope is more muscle, better recovery, or fat loss. The strong appetite boost makes it appealing to people on a bulk who want to eat more.
Doctors very rarely consider it for patients who are wasting away from illness, because the appetite boost can help them eat. Even then, most pick something else.
Does it actually work?
The honest answer: the proof is thin.
It does release growth hormone, that part is real. But the human studies are old and small, mostly for diagnostic testing. There is no and no anti-aging trial at all.
The hunger spike is very real too. One study showed it clearly raised food intake in healthy men.
The bigger issue is what it does to a marker called . Raising IGF-1 over a long time is a cancer worry. We do not have long-term safety data here. So you would be guessing.
what you’ve probably heard.
The claims floating around online, and how true they actually are.
“It cranks up your growth hormone and builds muscle.”
half trueA real GH burst does happen, that part holds up. The muscle claim does not: the human evidence is old, small, and mostly from diagnostic testing, with no and no muscle or anti-aging trial behind it.
“It's a clean, natural way to raise GH.”
not quiteAlong with GH it bumps cortisol and prolactin, and it raises , a long-term cancer worry with no safety data to settle it. A natural signal does not mean consequence-free.
“GHRP-2 hits harder than ipamorelin.”
half trueIt does give a bigger GH pulse. But a bigger pulse here also means a bigger cortisol and prolactin bump, the exact passengers ipamorelin skips. That cleaner trade is why most clinics moved on from this one.
“The hunger rush proves you got the real thing.”
not quiteA dramatic, can't-stop hunger spike usually means you got GHRP-6, which gets cross-labeled with GHRP-2 constantly. The only sure way to tell them apart is the molecular weight on a lab report.
How you take it.
People take it as a small shot under the skin.
The typical research dose people mention is around 200 mcg, sometimes a few times a day. The is short, about 15 to 60 minutes, so it does not last long in your body.
We are describing what users do, not recommending a plan. There is no dose because it is not an approved drug.
What to watch out for.
The common stuff
- A strong, fast hunger spike. For some people that is the goal. For others it is a real problem.
- It also raises two other hormones, cortisol and prolactin, which is not ideal.
The serious stuff
- It raises . Long-term high IGF-1 is linked to a cancer concern. There is no long-term safety data to settle this.
- It is banned in sports by WADA. A tested athlete will fail a drug test.
- Avoid it if you have had cancer recently. Avoid it if you have a history of binge eating, since the hunger spike makes that worse.
A buying tip and a warning in one: if you inject "GHRP-2" and get dramatic, can't-stop hunger in 20 minutes, you probably got GHRP-6 instead. They get mixed up a lot.
Talk to a real doctor before any of this. We are not your doctor.
Where people get it.
Here are the ways people get it, safest to riskiest.
- Brand. Does not exist. There is no GHRP-2.
- . Some pharmacies still make it with a prescription, around $120–$250 a month. But many clinics dropped it because of the appetite, cortisol, and prolactin profile.
- Research-only (). This is most of the supply. About $25–$80 a month. The catch: it gets cross-labeled with GHRP-6 or ipamorelin a lot.
- raw. The cheapest, $3–$10 a month. Still banned in sports no matter where it comes from.
If you buy research-grade, ask for a . That is a lab report showing what is in the vial. Make sure it lists the molecular weight, since that is the only way to tell GHRP-2 from GHRP-6.
Our honest take.
If a growth-hormone nudge were ever the call, ipamorelin does the same job with no cortisol or prolactin spike, and sermorelin works in a more natural way. For a healthy adult, that makes GHRP-2 a pass.
The one place it still fits is a sick patient under specialist care, where the runaway appetite is actually the goal. For everyone else, there is no reason to reach for the dated version.
The studies behind this.
We read the research so you don't have to. Here's where the facts on this page come from.
- 01— Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102 D, KP-102 LN, KP-102D, KP-102LN. Drugs in R&D. 2004;5(4):236-9. PMID: 15230633.
- 02Laferrère B, et al. Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men. The Journal of clinical endocrinology and metabolism. 2005;90(2):611-4. PMID: 15699539.
- 03Cox HD, et al. Detection of GHRP-2 and GHRP-6 in urine samples from athletes. Drug testing and analysis. 2015;7(5):439-44. PMID: 25809000.
- 04Yamamoto D, et al. GHRP-2, a GHS-R agonist, directly acts on myocytes to attenuate the dexamethasone-induced expressions of muscle-specific ubiquitin ligases, Atrogin-1 and MuRF1. Life sciences. 2008;82(9-10):460-6. PMID: 18191156.
- 05Semenistaya E, et al. Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin. Drug testing and analysis. 2015;7(10):919-25. PMID: 25869809.
- 06Bowers CY, et al. GHRP-2, GHRH and SRIF interrelationships during chronic administration of GHRP-2 to humans. Journal of pediatric endocrinology & metabolism : JPEM. 1996;9 Suppl 3:261-70. PMID: 8887169.
- 07Chen C, et al. Growth hormone-releasing peptide-2 (GHRP-2) does not act via the human growth hormone-releasing factor receptor in GC cells. Endocrine. 1998;9(1):71-7. PMID: 9798733.
- 08Kinoshita Y, et al. The arginine and GHRP-2 tests as alternatives to the insulin tolerance test for the diagnosis of adult GH deficiency in Japanese patients: a comparison. Endocrine journal. 2013;60(1):97-105. PMID: 23079545.
- 09Roh SG, et al. Is GHRH receptor essential to GHRP-2-induced GH secretion in primary cultured rat pituitary cells?. Endocrinology. 2002;143(5):1964-7. PMID: 11956179.
- 10Reverter-Branchat G, et al. On the road of dried blood spot sampling for antidoping tests: Detection of GHRP-2 abuse. Drug testing and analysis. 2021;13(3):510-522. PMID: 33197153.
- 11Granado M, et al. Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats. American journal of physiology. Endocrinology and metabolism. 2005;288(3):E486-92. PMID: 15507538.
- 12Chen C, et al. Effect of growth hormone-releasing peptide-2 (GHRP-2) and GH-releasing hormone (GHRH) on the the cAMP levels and GH release from cultured acromegalic tumours. Journal of neuroendocrinology. 1998;10(6):473-80. PMID: 9688350.
- 13Zeng P, et al. Ghrelin receptor agonist, GHRP-2, produces antinociceptive effects at the supraspinal level via the opioid receptor in mice. Peptides. 2014;55:103-9. PMID: 24607724.
- 14Ghigo E, et al. Growth hormone-releasing peptides. European journal of endocrinology. 1997;136(5):445-60. PMID: 9186261.
- 15Wu D, et al. The effects of GH-releasing peptide-6 (GHRP-6) and GHRP-2 on intracellular adenosine 3',5'-monophosphate (cAMP) levels and GH secretion in ovine and rat somatotrophs. The Journal of endocrinology. 1996;148(2):197-205. PMID: 8699133.
- 16Hu R, et al. Effects of GHRP-2 and Cysteamine Administration on Growth Performance, Somatotropic Axis Hormone and Muscle Protein Deposition in Yaks (Bos grunniens) with Growth Retardation. PloS one. 2016;11(2):e0149461. PMID: 26894743.
- 17Van den Berghe G, et al. The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone. Clinical endocrinology. 2002;56(5):655-69. PMID: 12030918.
- 18Chen C, et al. Effects of growth hormone-releasing peptide-2 (GHRP-2) on membrane Ca2+ permeability in cultured ovine somatotrophs. Journal of neuroendocrinology. 1995;7(3):179-86. PMID: 7606243.
- 19Balasubramaniam A, et al. GHRP-2 attenuates burn-induced dysfunctions in rodents. Advances in experimental medicine and biology. 2009;611:571-2. PMID: 19400318.
- 20Veldhuis JD, et al. Factors other than sex steroids modulate GHRH and GHRP-2 efficacies in men: evaluation using a GnRH agonist/testosterone clamp. The Journal of clinical endocrinology and metabolism. 2009;94(7):2544-50. PMID: 19351731.
- 21Arvat E, et al. Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Comparison with the effects of GHRH, TRH and hCRH. Peptides. 1997;18(6):885-91. PMID: 9285939.
- 22Yan M, et al. Effect of GHRH and GHRP-2 treatment in vitro on GH secretion and levels of GH, pituitary transcription factor-1, GHRH-receptor, GH-secretagogue-receptor and somatostatin receptor mRNAs in ovine pituitary cells. European journal of endocrinology. 2004;150(2):235-42. PMID: 14763922.
- 23Phung LT, et al. Effects of the administration of growth hormone-releasing peptide-2 (GHRP-2) orally by gavage and in feed on growth hormone release in swine. Domestic animal endocrinology. 2001;20(1):9-19. PMID: 11164330.
- 24Granado M, et al. Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle. American journal of physiology. Endocrinology and metabolism. 2005;289(6):E1007-14. PMID: 16030067.
- 25Ohara E, et al. Laparoscopic Sleeve Gastrectomy Resolves Low GHRP-2-Stimulated Growth Hormone Levels in Obese Patients. Obesity surgery. 2017;27(8):2214-2217. PMID: 28623445.
- 26Cheng J, et al. Growth hormone releasing peptides: a comparison of the growth hormone releasing activities of GHRP-2 and GHRP-6 in rat primary pituitary cells. Life sciences. 1997;60(16):1385-92. PMID: 9096259.
- 27Popławska M, et al. Identification of a novel growth hormone releasing peptide (a glycine analogue of GHRP-2) in a seized injection vial. Drug testing and analysis. 2019;11(1):162-167. PMID: 30051972.
- 28Sigalos JT, et al. The Safety and Efficacy of Growth Hormone Secretagogues. Sexual medicine reviews. 2018;6(1):45-53. PMID: 28400207.
- 29Okano M, et al. Influence of intravenous administration of growth hormone releasing peptide-2 (GHRP-2) on detection of growth hormone doping: growth hormone isoform profiles in Japanese male subjects. Drug testing and analysis. 2010;2(11-12):548-56. PMID: 21249726.
- 30Thomas A, et al. Identification of the growth-hormone-releasing peptide-2 (GHRP-2) in a nutritional supplement. Drug testing and analysis. 2010;2(3):144-8. PMID: 20878896.
- 31Okano M, et al. Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometry. Rapid communications in mass spectrometry : RCM. 2010;24(14):2046-56. PMID: 20552695.
- 32Kimura T, et al. Concordant and discordant adrenocorticotropin (ACTH) responses induced by growth hormone-releasing peptide-2 (GHRP-2), corticotropin-releasing hormone (CRH) and insulin-induced hypoglycemia in patients with hypothalamopituitary disorders: evidence for direct ACTH releasing activity of GHRP-2. Endocrine journal. 2010;57(7):639-44. PMID: 20431231.
- 33Arvat E, et al. Tyr-Ala-Hexarelin, a synthetic octapeptide, possesses the same endocrine activities of Hexarelin and GHRP-2 in humans. Journal of endocrinological investigation. 1999;22(2):91-7. PMID: 10195374.
- 34Roh SG, et al. Effects of muscarinic and adrenergic blockade on growth hormone secretion induced by growth hormone-releasing peptide-2 (GHRP-2) in ovariectomized ewes. Endocrine journal. 1997;44(6):861-5. PMID: 9622303.
- 35Phung LT, et al. The effects of growth hormone-releasing peptide-2 (GHRP-2) on the release of growth hormone and growth performance in swine. Domestic animal endocrinology. 2000;18(3):279-91. PMID: 10793268.
- 36Sinha DK, et al. Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Translational andrology and urology. 2020;9(Suppl 2):S149-S159. PMID: 32257855.
- 37Sheriff S, et al. Ghrelin receptor agonist, GHRP-2, attenuates burn injury-induced MuRF-1 and MAFbx expression and muscle proteolysis in rats. Peptides. 2009;30(10):1909-13. PMID: 19577604.
- 38Fukuda I, et al. Adult growth hormone deficiency: current concepts. Neurologia medico-chirurgica. 2014;54(8):599-605. PMID: 25070016.
- 39Doi N, et al. Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptide. Arzneimittel-Forschung. 2004;54(12):857-67. PMID: 15646370.
- 40Wideman L, et al. Synergy of L-arginine and GHRP-2 stimulation of growth hormone in men and women: modulation by exercise. American journal of physiology. Regulatory, integrative and comparative physiology. 2000;279(4):R1467-77. PMID: 11004017.
- 41Kageyama K, et al. Evaluation of growth hormone-releasing peptide-2 for diagnosis of thyrotropin-producing pituitary adenomas. Endocrine journal. 2018;65(10):1049-1054. PMID: 29973439.
- 42Camanni F, et al. Growth hormone-releasing peptides and their analogs. Frontiers in neuroendocrinology. 1998;19(1):47-72. PMID: 9465289.
- 43Chen C. The effect of two-day treatment of primary cultured ovine somatotropes with GHRP-2 on membrane voltage-gated K+ currents. Endocrinology. 2002;143(7):2659-63. PMID: 12072399.
- 44Lee HG, et al. Effects of dietary protein and growth hormone-releasing peptide (GHRP-2) on plasma IGF-1 and IGFBPs in Holstein steers. Domestic animal endocrinology. 2005;28(2):134-46. PMID: 15713362.
- 45Teramoto S, et al. Assessment of anterior pituitary reserve capacity based on growth hormone response to growth hormone-releasing peptide-2 test in the elderly. Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society. 2023;71:101545. PMID: 37295337.
- 46Chao YN, et al. Growth Hormone Releasing Peptide-2 Attenuation of Protein Kinase C-Induced Inflammation in Human Ovarian Granulosa Cells. International journal of molecular sciences. 2016;17(8). PMID: 27548147.
- 47Kageyama K, et al. Growth hormone-releasing peptide-2 stimulates secretion and synthesis of adrenocorticotropic hormone in mouse pituitary. Regulatory peptides. 2009;158(1-3):116-20. PMID: 19682503.
- 48Argente J, et al. Growth hormone-releasing peptides: clinical and basic aspects. Hormone research. 1996;46(4-5):155-9. PMID: 8950613.
- 49Liu Q, et al. The effect of GHRH, GHRP-2 and somatostatin on GH secretion by fetal pituitary. Journal of Tongji Medical University = Tong ji yi ke da xue xue bao. 1999;19(4):277-9. PMID: 12938517.
- 50Thomas A, et al. Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry. Analytical and bioanalytical chemistry. 2011;401(2):507-16. PMID: 21298258.
- 51Roh SG, et al. Differential regulation of GHRH-receptor and GHS-receptor expression by long-term in vitro treatment of ovine pituitary cells with GHRP-2 and GHRH. Endocrine. 2006;30(1):55-62. PMID: 17185792.
- 52Hu X, et al. Synthesis of Mono-PEGylated Growth Hormone Releasing Peptide-2 and Investigation of its Biological Activity. AAPS PharmSciTech. 2015;16(5):1213-9. PMID: 25761386.
- 53Wu D, et al. The effect of GH-releasing peptide-2 (GHRP-2 or KP 102) on GH secretion from primary cultured ovine pituitary cells can be abolished by a specific GH-releasing factor (GRF) receptor antagonist. The Journal of endocrinology. 1994;140(2):R9-13. PMID: 8169551.
- 54Granado M, et al. GH-releasing peptide-2 administration prevents liver inflammatory response in endotoxemia. American journal of physiology. Endocrinology and metabolism. 2008;294(1):E131-41. PMID: 17986630.
- 55Asakura Y, et al. Growth hormone response to GH-releasing peptide-2 in children. Journal of pediatric endocrinology & metabolism : JPEM. 2010;23(5):473-80. PMID: 20662346.
- 56Roh SG, et al. Characteristics of growth hormone secretion responsiveness to growth hormone-releasing peptide-2 (GHRP-2 or KP102) in calves. Endocrine journal. 1996;43(3):291-8. PMID: 8886623.
- 57Chihara K, et al. A simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency. European journal of endocrinology. 2007;157(1):19-27. PMID: 17609397.
- 58Hirotani C, et al. ACTH releasing activity of KP-102 (GHRP-2) in rats is mediated mainly by release of CRF. Naunyn-Schmiedeberg's archives of pharmacology. 2005;371(1):54-60. PMID: 15645295.
- 59Pihoker C, et al. Pharmacokinetics and pharmacodynamics of growth hormone-releasing peptide-2: a phase I study in children. The Journal of clinical endocrinology and metabolism. 1998;83(4):1168-72. PMID: 9543135.
- 60Van den Berghe G, et al. Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness. European journal of endocrinology. 1999;140(1):17-22. PMID: 10037246.
Learn about these too.
We're not your doctor, and this isn't medical advice. It's a plain-English summary of what the research says, so you can have a smarter conversation with someone who is.
Want the rest of the peptide world, in plain English?
New breakdowns, safety updates, and what's actually worth your money. Free. Unsubscribe in one click.